Mauna Kea Technologies' Board of Directors

Sacha Loiseau, Chairman of the Board
See management team

Albert Waxman, Member of the Board.
In 1998, Dr. Waxman founded Psilos, an investment company specialized in healthcare, with offices in New York, the San Francisco Bay Area and Santa Fe. Before founding Psilos, he was most recently the Chairman and Chief Executive Officer of Merit Behavioral Care and its predecessor companies, American Biodyne and Medco Behavioral Care, where he achieved very successful financial operations. Prior to American Biodyne, Dr. Waxman founded and served as President, Chairman and CEO of Diasonics, Inc., one of the first medical companies to provide ultrasound and magnetic resonance imaging in the U.S. Dr. Waxman holds several U.S. and foreign patents for display, imaging and diagnostic technologies and products. He has also been instrumental in the start-up and success of several other healthcare companies throughout his career.
Through his activities at Psilos, Dr. Waxman is chairman and/or a director of several Psilos companies. In addition to his current Psilos responsibilities, Dr. Waxman serves as a member of the Board of Directors of the New York City Investment Fund.
Dr. Waxman holds a Bachelor of Science degree in Electrical Engineering from the City College of New York and Master and Doctoral degrees in Electrical Engineering and Physics from Princeton University.

David Eichler, Member of the Board.
Mr. Eichler joined Psilos in April 1999 and has focused on investments in the healthcare services and medical technology areas. He works directly with many Psilos investments as an advisor on finance, strategy and business development, including recently as Acting Chief Financial Officer of Caregiver Services, Inc. He also has extensive experience as an advisor to senior management and boards of directors on M&A, financial restructuring and capital raising transactions.
Prior to joining Psilos, Mr. Eichler was an investment banker at Wasserstein Perella & Co., where he worked on numerous mergers and acquisitions and restructuring assignments as a member of the firm's Healthcare Group.
Mr. Eichler earned an MBA from the Darden Graduate School of Business Administration at the University of Virginia, where he received the Faculty Award for Academic Excellence (top 10% of class). He holds another masters degree in National Security Studies from Georgetown University and an undergraduate degree in Government and International Relations from Cornell University, where he graduated magna cum laude.

Bruno Donville, Member of the Board
Aged 44, Bruno Donville has been running the investment company CreAdev since its inception in 2002. After graduating from both Sciences-Po in Paris and HEC management school, Bruno began his career as a real estate broker. He moved on to corporate finance matters within a construction group and then in a British Investment Bank. In 1998, Bruno took over, with an associate, a French SME with 100 employees, specialized in cosmetics, in a difficult situation, and was joined by a private equity fund. In addition to MKT's, Bruno is an active boardmember of various businesses, including energy, retirement homes, B2B services and retail. Bruno represents CreAdev, a fund controlled by one of the largest French entrepreneurial family

Pascal Girin, Member of the Board
Pascal Girin, 46, brings 20 years of experience in the development, marketing and sales of medical devices to the board of Mauna Kea Technologies. Since July 2005, M. Girin has been serving as President, International of ev3, a leading worldwide medical device company one hundred percent focused on catheter-based or endovascular technologies for the minimally invasive treatment of vascular disease and disorders. Prior to this position, Mr. Girin served as General Manager, Europe of ev3, since September 2003. From September 1998 to August 2003, Mr. Girin served in various capacities at BioScience Europe Baxter Healthcare Corporation, most recently as Vice President. Mr. Girin received an Engineering Education at the French Ecole des Mines.

Philippe Maes, Member of the Board
Philippe Maes is one of Gemplus' co-founders, which he left in January 2000. From 1988 until 1992, Philippe was responsible for definition and development of new products, advanced products and technologies, application support and technical communication for Gemplus. In 1992, he was named general manager of Gemplus Card International in Germany. Prior to Gemplus, Philippe was in charge of the development of programmable products at Thomson Semiconductor. He oversaw the design of integrated circuits such as EPROM and EEPROM memories dedicated to smart card applications. From 1972 until 1981 Philippe was in charge of the applications department for Europe at National Semiconductor. Philippe holds a Ph.D. in electronics and medical engineering, and represents Finadvance.

Gavriel Meron, Member of the Board
Mr. Gavriel Meron founded the capsule endoscopy company Given Imaging, Ltd. (Nasdaq: GIVN) in 1998 and has served as Chief Executive Officer and member of the company's Board of Directors until 2006 when he became Executive Vice Chairman of the Board of Directors. Prior to this, Mr. Meron served as Chief Executive Officer of APPLItec Ltd., an Israeli designer and manufacturer of video cameras and systems, primarily for the medical endoscopy market. From 1993 to 1995, Mr. Meron was General Manager and Chief Operating Officer of Optibase Ltd., From 1988 to 1993, he was Chief Financial Officer of InterPharm Laboratories Ltd., a Swiss ethical pharmaceutical company. Mr. Meron holds an M.B.A. from Tel Aviv University and a B.A. in economics and statistics from the Hebrew University, Jerusalem.
Mr. Meron is an independent board member.